Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Total Debt Growth (5y) (2015 - 2026)

Analysis

Resmed (RMD) Total Debt Growth (5y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.62%
Mar 31, 2026 4.46%
Dec 31, 2025 1.97%
Sep 30, 2025 -2.77%
Jun 30, 2025 -10.61%
Mar 31, 2025 -13.23%
Dec 31, 2024 -12.24%
Sep 30, 2024 -11.02%
Jun 30, 2024 -10.98%
Mar 31, 2024 -5.48%
Dec 31, 2023 0.44%
Sep 30, 2023 20.42%
Jun 30, 2023 37.67%
Mar 31, 2023 14.52%
Dec 31, 2022 -2.35%
Sep 30, 2022 -4.60%
Jun 30, 2022 -6.15%
Mar 31, 2022 -9.93%
Dec 31, 2021 -13.97%
Sep 30, 2021 -11.11%